Agilent Technologies, Inc. - Diagnostics and Genomics SSEL XT2 CRE V2, 12
The Agilent SureSelect XT2 CRE V2, 12 reactions (part number 5190-9501) is a targeted enrichment solution designed for next-generation sequencing (NGS) applications. This kit enables comprehensive detection of carbapenem-resistant Enterobacteriaceae (CRE) genes by capturing and enriching relevant genomic regions prior to sequencing. The SureSelect XT2 technology provides high specificity and uniformity, ensuring reliable identification of resistance genes in clinical and research samples. The kit is optimized for use with Illumina sequencing platforms and supports up to 12 reactions per kit, facilitating efficient workflow and robust performance in microbial genomics studies.